The Role of Epidermal Growth Factor Receptor in Cancer Metastasis and Microenvironment
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Despite significant improvements in diagnosis, surgical techniques, and advancements in general patient care, the majority of deaths from cancer are caused by the metastases. There is an urgent need for an improved understanding of the cellular and molecular factors that promote cancer metastasis. The process of cancer metastasis depends on multiple interactions between cancer cells and host cells. Studies investigating the TGF α-EGFR signaling pathways that promote the growth and spread of cancer cells. Moreover, the signaling activates not only tumor cells, but also tumor-associated endothelial cells. TGF α-EGFR signaling in colon cancer cells creates a microenvironment that is conducive for metastasis, providing a rationale for efforts to inhibit EGFR signaling in TGF α-positive cancers. In this review, we describe the recent advances in our understanding of the molecular basis of cancer metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177 · cited 1×
“Tumor cell proliferation and survival depend on the vasculature to supply adequate oxygen and nutrients [39].”
BackgroundCunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Ullrich, A., Coussens, L., Hayflick, J. S., Dull, T. J., Gray, A., Tam, A. W., Lee, J., Yarden, Y., Libermann, T. A., Schlessinger, J., et al. (1984) · Nature · doi:10.1038/309418a0 · Cited by 2,752
Epidermal growth factor receptor (EGFR) signaling in cancer
Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006) · Gene · doi:10.1016/j.gene.2005.10.018 · Cited by 2,038
Saltz, L. B., Meropol, N. J., Loehrer, P. J., Needle, M. N., Kopit, J., & Mayer, R. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.182 · Cited by 1,694
The protein kinase B/Akt signalling pathway in human malignancy
Nicholson, K. M., & Anderson, N. G. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00271-6 · Cited by 1,639
Carpenter, G., & Cohen, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38983-5 · Cited by 1,622
Review of epidermal growth factor receptor biology
Herbst, R. S. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.041 · Cited by 1,390
The EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Receptor Protein-Tyrosine Kinases and Their Signal Transduction Pathways
van der Geer, P., Hunter, T., & Lindberg, R. A. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.001343 · Cited by 1,326
The Biology of Vascular Endothelial Growth Factor
Ferrara, N. (1997) · Endocrine Reviews · doi:10.1210/er.18.1.4 · Cited by 1,200
Ushiro, H., & Cohen, S. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43497-7 · Cited by 1,169
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
Grandis, J. R., Melhem, M. F., Gooding, W. E., Day, R., Holst, V. A., Wagener, M. M., Drenning, S. D., & Tweardy, D. J. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.11.824 · Cited by 1,113
Eberhard, A., Kahlert, S., Goede, V., Hemmerlein, B., Plate, K. H., & Augustin, H. G. (2000) · PubMed · Cited by 873
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Moustakas, A., & Heldin, C. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00550.x · Cited by 804
Schoppmann, S. F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., & Kerjaschki, D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64255-1 · Cited by 794
Liotta, L. A., Kleinerman, J. I., & Saidel, G. M. (1974) · PubMed · Cited by 766
Wang, W., Abbruzzese, J. L., Evans, D. B., Larry, L., Cleary, K. R., & Chiao, P. J. (1999) · PubMed · Cited by 726
Alroy, I., & Yarden, Y. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00412-2 · Cited by 714
Chen, W. S., Lazar, C. S., Poenie, M., Tsien, R. Y., Gill, G. N., & Rosenfeld, M. G. (1987) · Nature · doi:10.1038/328820a0 · Cited by 592
A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling
Carraway, K. L., & Cantley, L. C. (1994) · Cell · doi:10.1016/0092-8674(94)90564-9 · Cited by 587
Endothelial proliferation in tumours and normal tissues: Continuous labelling studies
Hobson, B., & Denekamp, J. (1984) · British Journal of Cancer · doi:10.1038/bjc.1984.66 · Cited by 565
The role of gelatinases in colorectal cancer progression and metastasis
Mook, O. R. F., Frederiks, W. M., & Van Noorden, C. J. F. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.09.006 · Cited by 511
Maruyama, K., Asai, J., Ii, M., Thorne, T., Losordo, D. W., & D'Amore, P. A. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060018 · Cited by 492
Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro
CARPENTER, G., KING, L., & COHEN, S. (1978) · Nature · doi:10.1038/276409a0 · Cited by 454
The seed and soil hypothesis: vascularisation and brain metastases
Fidler, I. J., Yano, S., Zhang, R.-D., Fujimaki, T., & Bucana, C. D. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(01)00622-2 · Cited by 432
Tumor Cell-Organ Microenvironment Interactions in the Pathogenesis of Cancer Metastasis
Langley, R. R., & Fidler, I. J. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0027 · Cited by 373
McConkey, D. J., Choi, W., Marquis, L., Martin, F., Williams, M. B., Shah, J., Svatek, R., Das, A., Adam, L., Kamat, A., et al. (2009) · Cancer and Metastasis Reviews · doi:10.1007/s10555-009-9194-7 · Cited by 368
Radinsky, R., Risin, S. A., Fan, D., Dong, Z., Bielenberg, D. R., Bucana, C. D., & Fidler, I. J. (1995) · PubMed · Cited by 353
Ciardiello, F., Bianco, R., Damiano, V., Lorenzo, S. D., Pepe, S., Placido, S. D., Fan, Z., Mendelsohn, J. M., Bianco, A. R., & Tortora, G. (1999) · PubMed · Cited by 332
The epidermal growth factor receptor as a target for cancer therapy.
Mendelsohn, J. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080003 · Cited by 330
平田, 晃. (2004) · Medical Entomology and Zoology · Cited by 298
Isobe, T., Okuyama, T., Toyoda, H., Komurasaki, T., Uchida, D., Takayama, Y., & Hanada, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.13.7495 · Cited by 269
Lee, M.-Y., Chou, C.-Y., Tang, M.-J., & Shen, M.-R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0234 · Cited by 256
Hirata, A., Ogawa, S.-I., Kometani, T., Kuwano, T., Naito, S., Kuwano, M., & Ono, M. (2002) · PubMed · Cited by 256
Shaheen, R. M., Ahmad, S. A., Liu, W., Reinmuth, N., Jung, Y. D., Tseng, W. W., Drazan, K. E., Bucana, C. D., Hicklin, D. J., & Ellis, L. M. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1936 · Cited by 235
Veale, D., Kerr, N., Gibson, G., Kelly, P., & Harris, A. L. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.306 · Cited by 219
Structure-Function relationships for the EGF/TGF-α family of mitogens
Groenen, L. C., Nice, E. C., & Burgess, A. W. (1994) · Growth Factors · doi:10.3109/08977199409010997 · Cited by 216
Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions
Barr, S., Thomson, S., Buck, E., Russo, S., Petti, F., Sujka-Kwok, I., Eyzaguirre, A., Rosenfeld-Franklin, M., Gibson, N. W., Miglarese, M., et al. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9121-7 · Cited by 197
Resnick, M. B., Routhier, J., Konkin, T., Sabo, E., & Pricolo, V. E. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0462 · Cited by 192
Pignochino, Y., Sarotto, I., Peraldo-Neia, C., Penachioni, J. Y., Cavalloni, G., Migliardi, G., Casorzo, L., Chiorino, G., Risio, M., Bardelli, A., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-631 · Cited by 173
Somatic Mutations of Epidermal Growth Factor Receptor in Bile Duct and Gallbladder Carcinoma
Leone, F., Cavalloni, G., Pignochino, Y., Sarotto, I., Ferraris, R., Piacibello, W., Venesio, T., Capussotti, L., Risio, M., & Aglietta, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1692 · Cited by 170
Kim, S.-J., Uehara, H., Karashima, T., Shepherd, D. L., Killion, J. J., & Fidler, I. J. (2003) · PubMed · Cited by 161
Yokoi, K., Thaker, P. H., Yazıcı, S., Rebhun, R. B., Nam, D., He, J., Kim, S.-J., Abbruzzese, J. L., Hamilton, S. R., & Fidler, I. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3700 · Cited by 147
EGFR and HER2 expression in advanced biliary tract cancer
Harder, J., Waiz, O., Otto, F., Geißler, M., Olschewski, M., Weinhold, B., Blum, H. E., Schmitt-Graeff, A. H., & Opitz, O. G. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.4511 · Cited by 136
Overview of angiogenesis: Biologic implications for antiangiogenic therapy
Ellis, L. M., Liu, W., Ahmad, S. A., Fan, F., Jung, Y. D., Shaheen, R. M., & Reinmuth, N. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90287-8 · Cited by 135
Liu, B., Fang, M., Schmidt, M., Lü, Y., Mendelsohn, J. M., & Fan, Z. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1201 · Cited by 128
Hemming, A. W., Davis, N. L., Kluftinger, A., Robinson, B., Quenville, N. F., Liseman, B., & Lcriche, J. (1992) · Journal of Surgical Oncology · doi:10.1002/jso.2930510304 · Cited by 128
Uhlman, D. L., Nguyen, P., Manivel, J. C., Zhang, G., Hagen, K., Fraley, E. E., Aeppli, D. M., & Niehans, G. A. (1995) · PubMed · Cited by 111
Relevance of biologic markers in colorectal carcinoma: A comparative study of a broad panel
Barozzi, C., Ravaioli, M., D’Errico, A., Grazi, G. L., Poggioli, G., Cavrini, G., Mazziotti, A., & Grigioni, W. F. (2002) · Cancer · doi:10.1002/cncr.10278 · Cited by 103
Pancreatic Cancer Cell Proliferation Is Phosphatidylinositol 3-Kinase Dependent
Perugini, R. A., McDade, T. P., Vittimberga, F. J., & Callery, M. P. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5833 · Cited by 100
Role of growth factors and their receptors in proliferation of microvascular endothelial cells
Suhardja, A. S., & Hoffman, H. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10245 · Cited by 73
Integration of novel agents in the treatment of colorectal cancer
Iqbal, S., & Lenz, H. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0884-0 · Cited by 70
Matsumoto, K., Date, K., Shimura, H., & Nakamura, T. (1996) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1996.tb00281.x · Cited by 61
Langley, R. R., Fan, D., Tsan, R. Z., Rebhun, R. B., He, J., Kim, S.-J., & Fidler, I. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3863 · Cited by 57
Sasaki, T., Nakamura, T., Rebhun, R. B., Cheng, H., Stemke‐Hale, K., Tsan, R. Z., Fidler, I. J., & Langley, R. R. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.071147 · Cited by 54
Self-citationA Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivo
Rajput, A., Koterba, A. P., Kreisberg, J. I., Foster, J. M., Willson, J. K. V., & Brattain, M. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2773 · Cited by 52
Toschi, L., & Cappuzzo, F. (2007) · The Oncologist · doi:10.1634/theoncologist.12-2-211 · Cited by 50
Sasaki, T., Kitadai, Y., Nakamura, T., Kim, J.-S., Tsan, R. Z., Kuwai, T., Langley, R. R., Fan, D., Kim, S.-J., & Fidler, I. J. (2007) · Neoplasia · doi:10.1593/neo.07667 · Cited by 46
Self-citationChang, H.-Y., Kao, M.-C., Way, T.-D., Ho, C.-T., & Fu, E. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf200598w · Cited by 45
New Treatment Options for Colorectal Cancer
Erlichman, C., & Sargent, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejme048151 · Cited by 39
Activation of MAP Kinases in Growth Responsive Pancreatic Cancer Cells
Douziech, N., Calvo, E. L., Lainé, J., & Morisset, J. (1999) · Cellular Signalling · doi:10.1016/s0898-6568(99)00030-3 · Cited by 38
Braamse, A. M. J., van Meijel, B., Visser, O. J., van Oppen, P., Boenink, A. D., Eeltink, C., Cuijpers, P. J., Huijgens, P. C., Beekman, A. T. F., & Dekker, J. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-361 · Cited by 26
Cited by
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
Crișan, G., Moldovean-Cioroianu, N. S., Timaru, D.-G., Andrieș, G., Căinap, C., & Chiș, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095023 · Cited by 337
PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.
Liao, H.-W., Hsu, J.-M., Xia, W., Wang, H.-L., Wang, Y.-N., Chang, W.-C., Arold, S. T., Chou, C.-K., Tsou, P.-H., Yamaguchi, H., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82826 · Cited by 155
“In addition to their function in normal development, aberrant expression of EGFR is involved in abnormal cell proliferation, reduced apoptosis, cell migration, metastasis, and angiogenesis in cancer patients (1, 2).”
BackgroundChainoglou, E., & Hadjipavlou-Litina, D. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1614560 · Cited by 92
Koustas, E., Karamouzis, M. V., Mihailidou, C., Schizas, D., & Papavassiliou, A. G. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.03.023 · Cited by 79
Pharmacological features, health benefits and clinical implications of honokiol
Khatoon, F., Ali, S., Kumar, V., Elasbali, A. M., Alhassan, H. H., Alharethi, S. H., Islam, A., & Hassan, M. I. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2120541 · Cited by 50
Metadata
- Authors
- Sasaki, T., Hiroki, K., & Yamashita, Y.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-8
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2157305173
- Cited by
- 285
- References
- 68
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.